Journal
JOURNAL OF THE ANUS RECTUM AND COLON
Volume 6, Issue 1, Pages 9-15Publisher
JAPAN SOC COLOPROCTOLOGY
DOI: 10.23922/jarc.2021-029
Keywords
tumor location; T1 colorectal cancer; lymph node metastasis; recurrence; risk factor; treatment strategy
Categories
Ask authors/readers for more resources
The incidence of T1 colorectal cancer is expected to rise due to the prevalence of colorectal cancer screening and progress in endoscopic treatment. Besides the known risk factors such as lymphovascular invasion, tumor differentiation, and depth of invasion, tumor location may also play a role in lymph node metastasis and recurrence. Therefore, treatment decisions for T1 colorectal cancer should take these factors into consideration.
The incidence of T1 colorectal cancer is expected to increase because of the prevalence of colorectal cancer screening and the progress of endoscopic treatment such as endoscopic submucosal dissection or endoscopic full-thickness resection. Currently, the requirement for additional surgery after endoscopic resection of T1 colorectal cancer is determined according to several treatment guidelines (in USA, Europe, and Japan) referring to the following pathological findings: lymphovascular invasion, tumor differentiation, depth of invasion, and tumor budding, all of which are reported to be risk factors for lymph node metastasis. In addition to these factors, in this review, we investigate whether tumor location, which is an objective factor, has an impact on the presence of lymph node metastasis and recurrence. From recent studies, left-sided location, especially the sigmoid colon in addition to rectum, could be a risk factor for lymph node metastasis and cancer recurrence. The treatment of T1 colorectal cancer should be managed considering these findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available